-
Textile-based conformable and breathable ultrasound imaging probe
Authors:
Takumi Noda,
Seiichi Takamatsu,
Michitaka Yamamoto,
Naoto Tomita,
Toshihiro Itoh,
Takashi Azuma,
Ichiro Sakuma,
Naoki Tomii
Abstract:
Daily monitoring of internal tissues with conformable and breathable ultrasound (US) imaging probes is promising for early detection of diseases. In recent years, textile substrates are widely used for wearable devices since they satisfy both conformability and breathability. However, it is not currently possible to use textile substrates for US probes due to the reflection or attenuation of US wa…
▽ More
Daily monitoring of internal tissues with conformable and breathable ultrasound (US) imaging probes is promising for early detection of diseases. In recent years, textile substrates are widely used for wearable devices since they satisfy both conformability and breathability. However, it is not currently possible to use textile substrates for US probes due to the reflection or attenuation of US waves at the air gaps in the textiles. In this paper, we fabricated a conformable and breathable US imaging probe by sandwiching the US elements between two woven polyester textiles on which copper electrodes were formed through electroless plating. The air gaps between the fibers at the electrode parts were filled with copper, allowing for high penetration of US waves. On the other hand, the non-electrode parts retain air gaps, leading to high breathability. The fabricated textile-based probe showed low flexural rigidity ($0.066 \times 10^{-4} N \cdot m^2/m$) and high air permeability ($11.7 cm^3 / cm^2 \cdot s$). Human neck imaging demonstrated the ability of the probe to monitor the pulsation of the common carotid artery and change in the internal jugular vein diameter, which lead to the early detection of health issues such as arteriosclerosis and dehydration.
△ Less
Submitted 7 November, 2023;
originally announced November 2023.
-
Health Guardian: Using Multi-modal Data to Understand Individual Health
Authors:
Vince S. Siu,
Kuan Yu Hsieh,
Italo Buleje,
Takashi Itoh,
Tian Hao,
Ben Civjan,
Nigel Hinds,
Bing Dang,
Jeffrey L. Rogers,
Bo Wen
Abstract:
Artificial intelligence (AI) has shown great promise in revolutionizing the field of digital health by improving disease diagnosis, treatment, and prevention. This paper describes the Health Guardian platform, a non-commercial, scientific research-based platform developed by the IBM Digital Health team to rapidly translate AI research into cloud-based microservices. The platform can collect health…
▽ More
Artificial intelligence (AI) has shown great promise in revolutionizing the field of digital health by improving disease diagnosis, treatment, and prevention. This paper describes the Health Guardian platform, a non-commercial, scientific research-based platform developed by the IBM Digital Health team to rapidly translate AI research into cloud-based microservices. The platform can collect health-related data from various digital devices, including wearables and mobile applications. Its flexible architecture supports microservices that accept diverse data types such as text, audio, and video, expanding the range of digital health assessments and enabling holistic health evaluations by capturing voice, facial, and motion bio-signals. These microservices can be deployed to a clinical cohort specified through the Clinical Task Manager (CTM). The CTM then collects multi-modal, clinical data that can iteratively improve the accuracy of AI predictive models, discover new disease mechanisms, or identify novel biomarkers. This paper highlights three microservices with different input data types, including a text-based microservice for depression assessment, a video-based microservice for sit-to-stand mobility assessment, and a wearable-based microservice for functional mobility assessment. The CTM is also discussed as a tool to help design and set up clinical studies to unlock the full potential of the platform. Today, the Health Guardian platform is being leveraged in collaboration with research partners to optimize the development of AI models by utilizing a multitude of input sources. This approach streamlines research efforts, enhances efficiency, and facilitates the development and validation of digital health applications.
△ Less
Submitted 2 October, 2023;
originally announced October 2023.
-
Health Guardian Platform: A technology stack to accelerate discovery in Digital Health research
Authors:
Bo Wen,
Vince S. Siu,
Italo Buleje,
Kuan Yu Hsieh,
Takashi Itoh,
Lukas Zimmerli,
Nigel Hinds,
Elif Eyigoz,
Bing Dang,
Stefan von Cavallar,
Jeffrey L. Rogers
Abstract:
This paper highlights the design philosophy and architecture of the Health Guardian, a platform developed by the IBM Digital Health team to accelerate discoveries of new digital biomarkers and development of digital health technologies. The Health Guardian allows for rapid translation of artificial intelligence (AI) research into cloud-based microservices that can be tested with data from clinical…
▽ More
This paper highlights the design philosophy and architecture of the Health Guardian, a platform developed by the IBM Digital Health team to accelerate discoveries of new digital biomarkers and development of digital health technologies. The Health Guardian allows for rapid translation of artificial intelligence (AI) research into cloud-based microservices that can be tested with data from clinical cohorts to understand disease and enable early prevention. The platform can be connected to mobile applications, wearables, or Internet of things (IoT) devices to collect health-related data into a secure database. When the analytics are created, the researchers can containerize and deploy their code on the cloud using pre-defined templates, and validate the models using the data collected from one or more sensing devices. The Health Guardian platform currently supports time-series, text, audio, and video inputs with 70+ analytic capabilities and is used for non-commercial scientific research. We provide an example of the Alzheimer's disease (AD) assessment microservice which uses AI methods to extract linguistic features from audio recordings to evaluate an individual's mini-mental state, the likelihood of having AD, and to predict the onset of AD before turning the age of 85. Today, IBM research teams across the globe use the Health Guardian internally as a test bed for early-stage research ideas, and externally with collaborators to support and enhance AI model development and clinical study efforts.
△ Less
Submitted 10 November, 2022;
originally announced November 2022.
